Matthew Strobeck
CIK 1377832 · last filed 2026-06-02
Matthew Strobeck is a corporate insider who has filed 88 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for QDEL, was dated Jun 2, 2026. Across all open-market trades the lifetime net is +$11.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.01M
5
88
$11.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QDEL | Director | 51,234 | $13.75 | $704.5K | $1.52M | 21 | 2026-06-02 |
| BDSX | Director | 133,096 | $24.86 | $3.31M | $6.89M | 18 | 2026-01-06 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | Director | 323,238 | $0.03 | $11.0K | $2.67M | 24 | 2024-01-25 |
| YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Director | 66,664 | — | — | $752.6K | 23 | 2016-01-28 |
| SANTARUS INC (SNTS) Delisted | Director | — | — | — | $0 | 1 | 2012-05-16 |
Recent Filings
88 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-02 | QDEL | Mixed | +6,829 | $0 | EDGAR |
| 2026-02-13 | QDEL | Buy (P) | +10,000 | $239.6K | EDGAR |
| 2026-01-06 | BDSX | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | QDEL | Grant (A) | — | $0 | EDGAR |
| 2025-05-27 | QDEL | Mixed | +4,929 | $0 | EDGAR |
| 2025-05-22 | BDSX | Grant (A) | — | $0 | EDGAR |
| 2024-11-06 | BDSX | Buy (P) | +40,000 | $55.9K | EDGAR |
| 2024-05-29 | QDEL | Mixed | +2,416 | $0 | EDGAR |
| 2024-05-23 | BDSX | Mixed | +347,840 | $0 | EDGAR |
| 2024-05-23 | QDEL | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.